O
6.62
0.03 (0.38%)
| Penutupan Terdahulu | 6.60 |
| Jumlah Dagangan | 1,371,362 |
| Harga / Jualan (P/S) | 27.09 |
| Harga / Buku (P/B) | 2.78 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -597.47% |
| EPS Cair (TTM) | -1.11 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -27.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 28.66% |
| Nisbah Semasa (MRQ) | 10.22 |
| Aliran Tunai Operasi (OCF TTM) | -145.46 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -87.96 M |
| Pulangan Atas Aset (ROA TTM) | -27.21% |
| Pulangan Atas Ekuiti (ROE TTM) | -57.19% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Ocular Therapeutix, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Nilai 35% | -0.1 |
| AI Insight info | NA |
| Penilaian Relatif info | NA |
| Kesihatan Kewangan info | -0.1 |
| Masa 35% | -0.4 |
| AI Technical info | NA |
| Osilator Teknikal info | -4.0 |
| Purata Bergerak Teknikal info | 5.0 |
| Wang Pintar 30% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Aktiviti Orang Dalam info | NA |
| Persekitaran | ×1.21 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | -21.3% |
| Persetujuan Tonggak | ×1.25 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | 3.1 |
| Skor Akhir | -0.27 |
|
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 3.82% |
| % Dimiliki oleh Institusi | 87.01% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |